Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in Hong Kong with limited liability)

(Stock Code: 648)

UPDATE ON CONDITIONS FOR

RESUMPTION OF TRADING

Reference is made to the announcements of China Wah Yan Healthcare Limited (the ''Company'') dated 30 April and 3 May 2021. Capitalized terms used in this announcement shall adopt the same meaning as those defined in the said announcements.

On 6 May 2021, the Stock Exchange has informed the Company of the imposition of an additional Resumption Condition to require the Company to re-comply with Rules 3.10(1) and 3.21 to have a minimum of three independent non-executive Directors and three members of its audit committee.

GENERAL

Trading in the shares of the Company will continue to be suspended pending fulfilment of the Resumption Conditions. Shareholders and potential investors of the Company should exercise caution when dealing in the shares of the Company.

For and on behalf of the board of

China Wah Yan Healthcare Limited

Lam Sung Him Gaston

Company Secretary

Hong Kong, 7 May 2021

As at the date of this announcement, the Board comprises Mr. Chan Ka Chung, Mr. Cheung Wai Kwan and Mr. Wang Jianguo as executive directors; and Mr. Chan Yee Ping, Michael and Ms. Hu Xuezhen as independent non-executive directors.

Attachments

  • Original document
  • Permalink

Disclaimer

China Wah Yan Healthcare Limited published this content on 07 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 May 2021 07:06:35 UTC.